Loading company…
Revelation Biosciences develops immune-modulating therapies, including Gemini, for inflammation-related health issues.
Founded in 2020 and based in San Diego, Revelation Biosciences develops therapies that modulate the immune response. Its lead product, Gemini, is an intravenous formulation being developed for patients facing trauma and infection. The company raised USD 5 mn in a July 2022 private placement, bringing total funding to USD 15.6 mn. It merged with Petra Acquisition Inc. in December 2021.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in